NASDAQ:AVBP

Arrivent Biopharma . Common Stock Stock Insider Trading

Healthcare > Biotechnology

Buy AVBP

*Your capital is at risk

$29.78

-0.140 (-0.468%)

At Close: Jun 03, 2026

Arrivent Biopharma . Common Stock Stock Insider Power

Based on the 92 latest insides trades, we have calculated the insider power to be negative at -39.60. In total, the insiders bought 35.93M and sold 127.75M AVBP shares in the last 92 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 92 transactions)	-39.60
● Buy	35.93M shares
● Sell	127.75M shares
84% Buy Activity Weak Negative Correlation
Buy Signal Low Confidence Feb 02, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -39.6. Confidence increased due to high data reliability score of 90. Supported by overwhelming buy-side pressure (84% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Jan 30, 2024 Buy	Common Stock C-Conversion	Healy James Director	Director	1 252 308 Value: $0
Jan 30, 2024 Buy	Common Stock P-Purchase	Healy James Director	Director	444 444 Value: $8.00M
Jan 30, 2024 Sell	Series B Preferred Stock C-Conversion	Gordon Carl L	Director	469 615 Value: $0
Jan 30, 2024 Sell	Series A Preferred Stock C-Conversion	Gordon Carl L	Director	821 827 Value: $0
Jan 30, 2024 Buy	Common Stock C-Conversion	Gordon Carl L	Director	821 827 Value: $0
Jan 30, 2024 Sell	Series B Preferred Stock C-Conversion	Healy James Director	Director	1 252 308 Value: $0
Jan 30, 2024 Buy	Common Stock C-Conversion	Healy James Director	Director	1 252 308 Value: $0
Jan 30, 2024 Buy	Common Stock P-Purchase	Healy James Director	Director	444 444 Value: $8.00M
Jan 30, 2024 Buy	Common Stock P-Purchase	Orbimed Advisors Llc	Director	222 222 Value: $4.00M
Jan 30, 2024 Sell	Series B Preferred Stock C-Conversion	Gordon Carl L	Director	469 615 Value: $0
Jan 30, 2024 Buy	Common Stock C-Conversion	Orbimed Advisors Llc	Director	821 827 Value: $0
Jan 30, 2024 Sell	Series B Preferred Stock C-Conversion	Orbimed Advisors Llc	Director	469 615 Value: $0
Jan 30, 2024 Sell	Series A Preferred Stock C-Conversion	Orbimed Advisors Llc	Director	821 827 Value: $0
Jan 30, 2024 Buy	Common Stock P-Purchase	Gordon Carl L	Director	222 222 Value: $4.00M
Jan 30, 2024 Sell	Series A Preferred Stock C-Conversion	Gordon Carl L	Director	821 827 Value: $0
Jan 30, 2024 Buy	Common Stock C-Conversion	Gordon Carl L	Director	821 827 Value: $0
Jan 25, 2024 Buy	Stock Option (right to buy) A-Award	Nolet Chris Director	Director	17 884 Value: $321.9K
Jan 25, 2024 Buy	Stock Option (right to buy) A-Award	Nolet Chris Director	Director	17 884 Value: $321.9K
Jan 25, 2024 Buy	Series A Preferred Stock	Gordon Carl L	Director	821 827 Value: $0
Jan 25, 2024 Buy	Series B Preferred Stock	Healy James Director	Director	1 252 308 Value: $0
Jan 25, 2024 Buy	Series B Preferred Stock	Hillhouse Investment Management, Ltd. 10 Percent Owner	10% Owner	313 076 Value: $0
Jan 25, 2024 Buy	Series A Preferred Stock	Orbimed Advisors Llc	Director	821 827 Value: $0
Jan 25, 2024 Buy	Series B Preferred Stock	Orbimed Advisors Llc	Director	469 615 Value: $0
Jan 25, 2024 Buy	Stock Option (right to buy)	Nolet Chris Director	Director	16 436 Value: $102.6K
Jan 25, 2024 Buy	Series A Preferred Stock	Hillhouse Investment Management, Ltd. 10 Percent Owner	10% Owner	3 616 041 Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks